U.S. Markets open in 37 hrs, 51 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 11.53 10:09 AM EDT | |
|---|---|---|
| Day High | 12.13 09:31 AM EDT |
|
| Range | 0.60 |
| Volume | 476,774 | |
|---|---|---|
| 30-Day Avg Vol | 1.19 M |
|
| Difference | -60.17% |
| Market Cap | 316.64 M | |
|---|---|---|
| Mkt Cap Chg | -3.73 M |
| Shares Out | 26.65 M | |
|---|---|---|
| % Shrs Traded | 1.79% | |
| 1yr EPS Est | -1.19 |
| 52-Wk Low | 0.45 12/23/08 | |
|---|---|---|
| 52-Wk High | 14.79 5/28/09 |
|
| Range | 14.34 |
| Prev Close | 12.02 7/1/09 | |
|---|---|---|
| Today's Open | 12.02 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 2.04 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -51.06 M | |
| Earnings (MRQ) | -6.50 M | |
| Next Earn Est | -0.475 | |
| Next Earnings | 08/03/2009 |
|
| EPS (TTM) | -1.44 | |
| 1yr EPS Growth | 17.36% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -9.00 | |
| PEG Ratio | — | |
| Return on Equity | -78.88 | |
| Beta | 9.01 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Vanda wants to gain an advantage in the field of neurological medicine. Vanda Pharmaceuticals is a pharmaceutical company that is developing several drugs for disorders of the central nervous system. The ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.475 8/3/09 | — — |
—
—
|
| Last Quarter | -0.22 3/31/09 | -0.24 3/31/09 |
-0.02
Missed
|
| 2 Quarters Ago | -0.36 12/31/08 | -0.28 12/31/08 |
0.08
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -148,671.00 | -530,805.00 |
| Operating Income | -6.56 M | -52.85 M |
| Net Income | -6.50 M | -51.06 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts